Retraction notice to "Ameliorative effects of vanillin against pentylenetetrazole-induced epilepsy and associated memory loss in mice: The role of Nrf2/HO-1/NQO1 and HMGB1/RAGE/TLR4/NFκB pathways" [Int. Immunopharmacol. 129 (2024) 111657]
- PMID: 40992979
- DOI: 10.1016/j.intimp.2025.115575
Retraction notice to "Ameliorative effects of vanillin against pentylenetetrazole-induced epilepsy and associated memory loss in mice: The role of Nrf2/HO-1/NQO1 and HMGB1/RAGE/TLR4/NFκB pathways" [Int. Immunopharmacol. 129 (2024) 111657]
Retraction of
-
Ameliorative effects of vanillin against pentylenetetrazole-induced epilepsy and associated memory loss in mice: The role of Nrf2/HO-1/NQO1 and HMGB1/RAGE/TLR4/NFκB pathways.Int Immunopharmacol. 2024 Mar 10;129:111657. doi: 10.1016/j.intimp.2024.111657. Epub 2024 Feb 9. Int Immunopharmacol. 2024. Retraction in: Int Immunopharmacol. 2025 Sep 23:115575. doi: 10.1016/j.intimp.2025.115575. PMID: 38335655 Retracted.
References
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous